Work

Experimental p38 MAPK inhibitors for the treatment of urological cancers: observations from early clinical trials

Year: 2026

Type: article

Source: Expert Opinion on Investigational Drugs

DOI: 10.1080/13543784.2026.2629507

Authors: Charalampos Fragkoulis, Panagiotis Velissarios Stamatakos, Nikolaos Kontolatis, Konstantinos Gklinos, Georgios Papavasileiou, Athanasios Dellis

Institutions: General Hospital of Athens G. Genimatas, Hellenic Red Cross, Red Cross Hospital, National and Kapodistrian University of Athens

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7128545721

FWCI: 1.939

Cites: 42

Cited by: 1

Related to: